Xortx Therapeutics (TSE:XRTX) has released an update.
XORTX Therapeutics Inc., a pharmaceutical company specializing in treatments for progressive kidney disease, has announced their participation in multiple investor conferences in Spring 2024, including key events in New York, Scottsdale, and San Diego. The company’s CEO, Dr. Allen Davidoff, is set to deliver updates and engage in one-on-one meetings with investors. Additionally, XORTX has contracted LHA Investor Relations for a six-month term to enhance investor relations efforts.
For further insights into TSE:XRTX stock, check out TipRanks’ Stock Analysis page.
